ResearcherNecmettin Erbakan UniversityNo recent work listed
Hasibe Cıngıllı Vural
Matched on ORCID iD 0000-0003-2564-7807; OpenAlex author ID A5055102226. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2022: 2 papers
Papers 2
- Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediated mitochondrial dysfunction in pancreat… Co-author DOI 10.1007/s11033-022-08006-8↗
- Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitochondrial membrane potential. Last author DOI 10.1016/j.tiv.2022.105458↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hatice Gül Dursun · 2 shared papers, 2022 · strength 0.45
- Paper Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediat… DOI 10.1007/s11033-022-08006-8↗
- Paper Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitoc… DOI 10.1016/j.tiv.2022.105458↗
- Ebru Güçlü · 2 shared papers, 2022 · strength 0.45
- Paper Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediat… DOI 10.1007/s11033-022-08006-8↗
- Paper Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitoc… DOI 10.1016/j.tiv.2022.105458↗
- İlknur Çınar Ayan · 2 shared papers, 2022 · strength 0.45
- Paper Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediat… DOI 10.1007/s11033-022-08006-8↗
- Paper Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitoc… DOI 10.1016/j.tiv.2022.105458↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.